Stevanato Group S.p.A. (STVN)
Makes glass vials, syringes, and machines that package medicines for drugmakers worldwide.
$19.85+0.00%Healthcare
StockGlow Score
Leaning Bullish
BearishBullish
1 year ago-21.0%
The outlook
STVN trades at $19.85 with analyst consensus leaning toward Buy, and the average price target sits about 23% above the current level. The stock is positioned above both its 50- and 200-day moving averages and trades roughly midway in its 52-week range, reflecting a balanced technical picture between recent lows and highs.
What’s behind the score
Analyst consensusBuy — 1.5 avg of 10 analysts
Price trendAbove its 50- & 200-day averages
52-week range46% of the way from its 52-week low to high
Price targetAvg target +23% vs current price
Analyst price target
~12-month · 10 analysts$24.45average target+23.2% vs now
Now $19.85
Low $17.50High $32.00
Published targets from Wall Street analysts (public data) — what analysts expect over roughly a year. This is not a StockGlow forecast and not a recommendation. Analyst targets are frequently wrong.
Market cap
$5.42B
52-wk high
$28.00
52-wk low
$12.89
50-day avg
$18.37
200-day avg
$18.84
Trailing P/E
34.2